Schonfeld Strategic Advisors LLC Century Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$3.19 - $5.32 $296,941 - $495,212	93,085 New	93,085 $389,000
Q1 2022 May 16, 2022	SELL	$11.62 - $15.92 $142,926 - $195,816	-12,300 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$13.93 - $23.62 $18,109 - $30,706	-1,300 Reduced 9.56%	12,300 $195,000
Q3 2021 Nov 16, 2021	SELL	$20.8 - $31.93 $93,600 - $143,685	-4,500 Reduced 24.86%	13,600 $342,000
Q2 2021 Aug 16, 2021	BUY	$22.45 - $29.34 $406,345 - $531,054	18,100 New	18,100 $531,000

36.9M

8.7K

10.2K

Ticker IPSC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,881,800
Market Cap $61.8M
Description
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.